دورية أكاديمية

Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma

التفاصيل البيبلوغرافية
العنوان: Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma
المؤلفون: Latenstein, A.E.J. (Anouk E.J.), van der Geest, L.G.M. (Lydia G.M.), Bonsing, B.A. (Bert), Groot Koerkamp, B. (Bas), Haj Mohammad, N. (Nadia), Hingh, I.H.J.T. (Ignace) de, Meijer, V.E. (Vincent) de, Molenaar, I.Q. (I. Quintus), Santvoort, H.C. (Hjalmar) van, Tienhoven, G. (G.) van, Verheij, J. (Joanne), Vissers, P.A.J. (P. A J), de Vos-Geelen, J. (Judith), Busch, O.R. (Olivier R.), Eijck, C.H.J. (Casper) van, Laarhoven, H.W.M. (Hanneke) van, Besselink, M.G. (Marc G.), Wilmink, J.W. (Johanna)
المصدر: European Journal of Cancer vol. 125, pp. 83-93
سنة النشر: 2020
المجموعة: RePub - Publications from Erasmus University, Rotterdam
مصطلحات موضوعية: Epidemiology, Incidence, Pancreatic cancer, Survival
الوصف: Background: In recent years, new treatment options have become available for pancreatic ductal adenocarcinoma (PDAC) including 5-fluorouracil, leucovorin, irinotecan and oxaliplatin. The impact hereof has not been assessed in nationwide cohort studies. This population-based study aimed to investigate nationwide trends in incidence, treatment and survival of PDAC. Materials and methods: Patients wit
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: English
العلاقة: http://repub.eur.nl/pub/122651Test; urn:hdl:1765/122651
DOI: 10.1016/j.ejca.2019.11.002
الإتاحة: https://doi.org/10.1016/j.ejca.2019.11.002Test
http://repub.eur.nl/pub/122651Test
حقوق: info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.865F888F
قاعدة البيانات: BASE